Since some studies also reported an association of S100B levels with depression severity, S100B levels were controlled for this association and monitored at baseline and after treatment in order to elucidate whether S100B levels in melancholic depression represent a trait marker for antidepressant responsiveness or a state marker for the current severity of the disorder. The gene discussed is S100B; the disease is depressive symptom measurement.